Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment

Transplantation

Volumn 62, Issue 8, 1996, Pages 1102-1108

  Craigen, Jennifer L ^a   Grundy, Jane E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFECTION RISK; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ANTIGENS, CD58; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FIBROBLASTS; FOSCARNET; GANCICLOVIR; GRAFT REJECTION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; ORGAN TRANSPLANTATION; UP-REGULATION; VIRAL PROTEINS;

EID: 0029858370     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199610270-00014     Document Type: Article

References (40)

1. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478.
2. Dunn DL, Mayoral JL, Gillingham KJ, et al. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 1991; 51: 98.
3. Forman SJ, Zaia JA. Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood 1994; 83: 2392.
4. Grundy JE, Shanley JD, Griffiths PD. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet 1987; 2: 996.
5. Wingard JR, Chen DY, Burns WH, et al. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 1988; 71: 1432.
6. Miller W, Flynn P, McCullough J, et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood 1986; 67: 1162.
7. Dummer JS, Montero CG, Griffith BP, Hardesty RL, Paradis IL, Ho M. Infections in heart-lung transplant recipients. Transplantation 1986; 41: 725.
8. Ouwehand AJ, Balk AH, Baan CC, et al. Cytomegalovirus infection and allospecific cytotoxic activity of graft-infiltrating cells after heart transplantation. J Med Virol 1994; 42: 175.
9. Arnold JC, Portmann BC, O'Grady JG, Naoumov NV, Alexander GJ. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology 1992; 16: 285.
10. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
11. Grundy JE, Downes KL. Up-regulation of LFA-3 and ICAm-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology 1993; 78: 405.
12. Sedmak DD, Knight DA, Vook NC, Waldman JW. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 1994; 58: 1379.
13. van Dorp WT, van Wieringen PA, Marselis-Jonges E, et al. Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation 1993; 55: 1367.
14. Roy DM, Grundy JE. Evaluation of neutralizing antibody titers against human cytomegalovirus in intravenous gamma globulin preparations. Transplantation 1992; 54: 1109.
15. Rose JS, Grundy JE. Beta 2 microglobulin on the envelope of urinary cytomegalovirus is not associated with host class I human leukocyte antigen alpha chain. J Gen Virol 1992; 73: 507.
16. Schols D, Snoeck R, Neyts J, De-Clercq E. Detection of immediate early, early and late antigens of human cytomegalovirus by flow cytometry. J Virol Methods 1989; 26: 247.
17. Janossy G, Amlot PA. Immunofluorescence and immunohistochemistry. In: Klaus GGB, ed. Lymphocytes: a practical approach, Oxford: IRL, 1987: 70.
18. Watson JV. Immunofluorescence data. In: Flow cytometry: data analysis, basic concepts and statistics, Cambridge: Cambridge University, 1992: 101.
19. Barnes PD, Grundy JE. Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus. J Gen Virol 1992; 73: 2395.
20. Piela-Smith TH, Broketa G, Hand A, Korn JH. Regulation of ICAM-I expression and function in human dermal fibroblasts by IL-4. J Immunol 1992; 146: 1375.
21. Rothlein R, Czajkowski M, O'Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by proinflammatory cytokines. regulation by pharmacologic agents and neutralizing antibodies. J Immunol 1988; 141: 1665.
22. Smith PD, Saini SS, Raffeld M, Manischewitz JF, Wahl SM. Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages. J Clin Invest 1992; 90: 1642.
23. Moses AV, Gar̈nett HM. The effect of human cytomegalovirus on the production and biologic action of interleukin-1. J Infect Dis 1990; 162; 381.
24. Grundy JE, Pahal GS, Akbar AN. Increased adherence of CD2 peripheral blood lymphocytes to cytomegalovirus-infected fibroblasts is blocked by anti-LFA-3 antibody. Immunology 1993; 78: 413.
25. Liu B, Stinski MF. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol 1992; 66: 4434.
26. Britt WJ, Auger D. Human cytomegalovirus virion-associated protein with kinase activity. J Virol 1986; 59: 185.
27. Hermiston TW, Malone CL, Stinski MF. Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter. J Virol 1990; 64: 3532.
28. Jenkins DE, Martens CL, Mocarski ES. Human cytomegalovirus late protein encoded by ie2: a trans-activator as well as a repressor of gene expression. J Gen Virol 1994; 75: 2337.
29. Shepp DH, Dandliker PS, de-Miranda P, et al. Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia. Ann Intern Med 1985; 103: 368.
30. Churchill MA, Zaia JA, Forman SJ, Sheibani K, Azumi N, Blume KG. Quantitation of human cytomegalovirus DNA in lungs from bone marrow transplant recipients with interstitial pneumonia. J Infect Dis 1987; 155: 501.
31. Slavin MA, Gleaves CA, Schoch HG, Bowden RA. Quantification of cytomegalovirus in bronchoalveolar lavage fluid after allogeneic marrow transplantation by centrifugation culture. J Clin Microbiol 1992; 30: 2776.
32. Hu KQ, Yu CH, Vierling JM. Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein. Proc Natl Acad Sci USA 1992; 89: 11441.
33. Sandvej KB, Hamilton-Dutoit SJ, Pallesen G. Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAm-I and LFA-3 in Hodgkin and Reed-Sternberg cells: a morphometric analysis. Leukemia Lymphoma 1993; 9: 95.
34. Stenberg RM, Stinski MF. Autoregulation of the human cytomegalovirus major immediate-early gene. J Virol 1985; 56: 676.
35. Tevethia MJ, Spector DJ, Leisure KM, Stinski MF. Participation of two human cytomegalovirus immediate early gene regions in transcriptional activation of adenovirus promoters. Virology 1987; 161: 276.
36. Davis MG, Kenney SC, Kamine J, Pagano JS, Huang ES. Immediate-early gene region of human cytomegalovirus transactivates the promoter of human immunodeficiency virus. Proc Natl Acad Sci USA 1987; 84: 8642.
37. Adams DH, Hubscher SG, Shaw J, Rothlein R, Neuberger JM. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 1989; 2: 1122.
38. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAm-1 and LFA-1. Science 1992; 255: 1125.
39. Talento A, Nguyen M, Blake T, et al. A single administration of LFA-I antibody confers prolonged allograft survival. Transplantation 1993; 55: 418.
40. Zeng Y, Gage A, Montag A, Rothlein R, Thistlethwaite JR, Bluestone JA. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAm-1 antibodies. Transplantation 1994; 58: 681.